Global Epigenetics Market Size & Outlook, 2023-2030
Global epigenetics market, 2018-2030 (US$M)
Related Markets
Global epigenetics market highlights
- The global epigenetics market generated a revenue of USD 14,627.3 million in 2023 and is expected to reach USD 39,152.2 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 15.1% by 2030.
- In terms of segment, reagents accounted for a revenue of USD 4,893.3 million in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 14,627.3 million |
| Market revenue in 2030 | USD 39,152.2 million |
| Growth rate | 15.1% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 38.2% of the global epigenetics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 69.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epigenetics Market Scope
Epigenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global epigenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 33.45% in 2023. Horizon Databook has segmented the Global epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
Market Dynamics
The global Epigenetics market is expected to increase as a result of the increasing number of epigenetic applications in the treatment various life-threatening disorders including cancer and other illnesses. Because epigenetics has been shown to be highly effective in treating specific types of cancer, many research institutes are deeply investigating it with the aim of producing essential vaccines and drugs for abnormalities that have yet to receive any effective therapies assigned to them. For instance, in 2022, according to American Cancer Society, it was estimated that, Several organizations, including the National Cancer Institute, Human Epigenome Consortium, and National Institutes of Health, have pushed for more funding in epigenetics, both for research and for commercialization, which is expected to support worldwide expansion in the coming years.
Reasons to subscribe to Global epigenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global epigenetics market databook
-
Our clientele includes a mix of epigenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global epigenetics market , including forecasts for subscribers. This global databook contains high-level insights into Global epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global epigenetics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Epigenetics market size, 2023 (US$M)
Global epigenetics market share, by product, 2023 & 2030 (%, US$M)
Epigenetics market: Opportunity assessment by country
Global epigenetics market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
